Asia Pacific Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity

December 2021 | 140 pages | ID: A4F52B2D0668EN
GMD Research

Abstracts

Bioelectric medicines, also known as electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. Asia Pacific bioelectric medicine market will grow by 9.3% annually with a total addressable market cap of $60.93 billion over 2021-2030 owing to the growing geriatric population and rising acceptance of bioelectric medicines.

Highlighted with 68 tables and 42 figures, this 140-page report “Asia Pacific Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific bioelectric medicine market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2030 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific bioelectric medicine market in every aspect of the classification from perspectives of Product Type, End User, and Country.

Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Implantable Bioelectric Medicine
• Cardiac Pacemaker
• Implantable Cardioverter Defibrillators (ICD)
• Spinal Cord Stimulators (split into Chronic Pain, Failed Back Syndrome (FBSS), Ischemia by application)
• Cochlear Implants
• Deep Brain Stimulators (split into Parkinson’s Disease, Tremor, Depression, Other Deep Brain Stimulation Applications by application)
• Vagus Nerve Stimulators
• Sacral Nerve Stimulators (split into Urinary Incontinence and Fecal Incontinence by application)
• Retinal Implants
• Other Implantable Bioelectric Medicines
• Non-invasive Bioelectric Medicine
• Transcutaneous Electrical Nerve Stimulators
• Transcranial Magnetic Stimulation (TMS)
• Pulsed Electromagnetic Field Therapy
• Other Non-invasive Bioelectric Medicines

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Hospitals and Clinics
• Research Institutes
• Individual Users

Geographically, the following national/local markets are fully investigated:

• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of the regional market by country and split of key national markets by Product Type and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in Asia Pacific bioelectric medicine market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

Abbott Laboratories

BIOTRONIK SE & Co. KG

Boston Scientific Corporation

Cochlear Limited

electroCore, Inc.

Inspire Medical Systems, Inc.

LivaNova PLC

Medtronic PLC

NeuroMetrix, Inc

Nevro Corp.

Nuvectra Corporation

OMRON CORPORATION

Pixium Vision

Second Sight Medical Products Inc

SetPoint Medical

Sonova Holding AG

St. Jude Medical, Inc.

Stimwave LLC

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF ASIA PACIFIC MARKET BY PRODUCT TYPE

3.1 Market Overview by Product Type
3.2 Implantable Bioelectric Medicine
  3.2.1 Cardiac Pacemaker
  3.2.2 Implantable Cardioverter Defibrillators (ICD)
  3.2.3 Spinal Cord Stimulators
  3.2.4 Cochlear Implants
  3.2.5 Deep Brain Stimulators
  3.2.6 Vagus Nerve Stimulators
  3.2.7 Sacral Nerve Stimulators
  3.2.8 Retinal Implants
  3.2.9 Other Implantable Bioelectric Medicines
3.3 Non-invasive Bioelectric Medicine
  3.3.1 Transcutaneous Electrical Nerve Stimulators
  3.3.2 Transcranial Magnetic Stimulation (TMS)
  3.3.3 Pulsed Electromagnetic Field Therapy
  3.3.4 Other Non-invasive Bioelectric Medicines

4 SEGMENTATION OF ASIA PACIFIC MARKET BY END USER

4.1 Market Overview by End User
4.2 Hospitals and Clinics
4.3 Research Institutes
4.4 Individual Users

5 ASIA-PACIFIC MARKET 2020-2030 BY COUNTRY

5.1 Overview of Asia-Pacific Market
5.2 Japan
5.3 China
5.4 Australia
5.5 India
5.6 South Korea
5.7 Rest of APAC Region

6 COMPETITIVE LANDSCAPE

6.1 Overview of Key Vendors
6.2 New Product Launch, Partnership, Investment, and M&A
6.3 Company Profiles
Abbott Laboratories
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cochlear Limited
electroCore, Inc.
Inspire Medical Systems, Inc.
LivaNova PLC
Medtronic PLC
NeuroMetrix, Inc
Nevro Corp.
Nuvectra Corporation
OMRON CORPORATION
Pixium Vision
Second Sight Medical Products Inc
SetPoint Medical
Sonova Holding AG
St. Jude Medical, Inc.
Stimwave LLC

7 INVESTING IN ASIA PACIFIC MARKET: RISK ASSESSMENT AND MANAGEMENT

7.1 Risk Evaluation of Asia Pacific Market
7.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Asia Pacific Bioelectric Medicine Market in Balanced Perspective, 2020-2030
Table 2. Growth Rate of World GDP, 2020-2022
Table 3. Projection of Asia Pacific Disease Incidences Treated by Bioelectric Medicine, 2019-2030, million
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Selected Examples of Product Recalls
Table 6. Main Product Trends and Market Opportunities in Asia Pacific Bioelectric Medicine Market
Table 7. Asia Pacific Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 8. Asia Pacific Implantable Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 9. Asia Pacific Bioelectric Medicine Market: Spinal Cord Stimulators by Application, 2019-2030, $ mn
Table 10. Asia Pacific Bioelectric Medicine Market: Deep Brain Stimulators by Application, 2019-2030, $ mn
Table 11. Asia Pacific Bioelectric Medicine Market: Sacral Nerve Stimulators by Application, 2019-2030, $ mn
Table 12. Asia Pacific Non-invasive Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 13. Asia Pacific Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 14. APAC Bioelectric Medicine Market by Country, 2019-2030, $ mn
Table 15. Japan Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 16. Japan Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 17. China Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 18. China Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 19. Australia Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 20. Australia Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 21. India Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 22. India Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 23. South Korea Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 24. South Korea Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 25. Bioelectric Medicine Market in Rest of APAC by Country, 2019-2030, $ mn
Table 26. Spinal Cord Stimulation Device Market by Key Vendor, 2019, %
Table 27. Cochlear Implant Market by Key Vendor, 2019, %
Table 28. Pacemaker and ICD Market by Key Vendor, 2019, %
Table 29. FDA Approved Products of Key Vendors
Table 30. Abbott Laboratories: Company Snapshot
Table 31. Abbott Laboratories: Business Segmentation
Table 32. Abbott Laboratories: Product Portfolio
Table 33. Abbott Laboratories: Revenue, 2018-2020, $ mn
Table 34. BIOTRONIK SE & Co. KG: Company Snapshot
Table 35. Boston Scientific Corp.: Company Snapshot
Table 36. Boston Scientific Corp.: Business Segmentation
Table 37. Boston Scientific Corp.: Product Portfolio of Medical Devices
Table 38. Cochlear Limited: Company Snapshot
Table 39. Cochlear Limited: Operational Overview with Sales Revenue ($ mn) and Sales Volume (units), 2020-2021
Table 40. Cochlear Limited: Product Portfolio
Table 41. electroCore, Inc.: Company Snapshot
Table 42. Inspire Medical Systems, Inc..: Company Snapshot
Table 43. LivaNova PLC: Company Snapshot
Table 44. LivaNova PLC: Product Portfolio
Table 45. Medtronic Inc.: Company Snapshot
Table 46. Medtronic Inc.: Net Revenue by Segment, 2018-2020, $ bn
Table 47. Medtronic Inc.: Net Revenue by Region, 2017-2019, $ bn
Table 48. Medtronic Inc.: Product Portfolio of Medical Devices
Table 49. Medtronic Inc.: Product Portfolio of Bioelectric Medicine
Table 50. NeuroMetrix, Inc: Company Snapshot
Table 51. NeuroMetrix, Inc: Product Portfolio
Table 52. Nevro Corp.: Company Snapshot
Table 53. Nevro Corp.: Product Portfolio
Table 54. Nuvectra Corporation: Company Snapshot
Table 55. Omron Corporation: Company Snapshot
Table 56. Omron Corporation: Business Segmentation
Table 57. Pixium Vision: Company Snapshot
Table 58. Pixium Vision: Product Portfolio
Table 59. Second Sight Medical Products Inc: Company Snapshot
Table 60. Second Sight Medical Products Inc: Product Portfolio
Table 61. SetPoint Medical: Company Snapshot
Table 62. Sonova Holding AG: Company Snapshot
Table 63. Sonova Holding AG: Main Brands and Products
Table 64. St. Jude Medical, Inc.: Company Snapshot
Table 65. Stimwave LLC: Company Snapshot
Table 66. Stimwave LLC: Product Portfolio
Table 67. Risk Evaluation for Investing in Asia Pacific Market, 2020-2030
Table 68. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2030
Figure 4. Asia Pacific Bioelectric Medicine Market, 2019-2030, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Bioelectric Medicine Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million
Figure 8. World Population 65 and over, % of Total Population, 1950-2060
Figure 9. Primary Restraints and Impact Factors of Asia Pacific Bioelectric Medicine Market
Figure 10. Investment Opportunity Analysis
Figure 11. Porter’s Fiver Forces Analysis of Asia Pacific Bioelectric Medicine Market
Figure 12. Breakdown of Asia Pacific Bioelectric Medicine Market by Product Type, 2020-2030, % of Sales Revenue
Figure 13. Asia Pacific Addressable Market Cap in 2021-2030 by Product Type, Value ($ mn) and Share (%)
Figure 14. Asia Pacific Bioelectric Medicine Market: Implantable Bioelectric Medicine, 2019-2030, $ mn
Figure 15. Asia Pacific Bioelectric Medicine Market: Cardiac Pacemaker, 2019-2030, $ mn
Figure 16. Asia Pacific Bioelectric Medicine Market: Implantable Cardioverter Defibrillators (ICD), 2019-2030, $ mn
Figure 17. Asia Pacific Bioelectric Medicine Market: Spinal Cord Stimulators, 2019-2030, $ mn
Figure 18. Asia Pacific Bioelectric Medicine Market: Cochlear Implants, 2019-2030, $ mn
Figure 19. Asia Pacific Bioelectric Medicine Market: Deep Brain Stimulators, 2019-2030, $ mn
Figure 20. Asia Pacific Bioelectric Medicine Market: Vagus Nerve Stimulators, 2019-2030, $ mn
Figure 21. Asia Pacific Bioelectric Medicine Market: Sacral Nerve Stimulators, 2019-2030, $ mn
Figure 22. Asia Pacific Bioelectric Medicine Market: Retinal Implants, 2019-2030, $ mn
Figure 23. Asia Pacific Bioelectric Medicine Market: Other Implantable Bioelectric Medicines, 2019-2030, $ mn
Figure 24. Asia Pacific Bioelectric Medicine Market: Non-invasive Bioelectric Medicine, 2019-2030, $ mn
Figure 25. Asia Pacific Bioelectric Medicine Market: Transcutaneous Electrical Nerve Stimulators, 2019-2030, $ mn
Figure 26. Asia Pacific Bioelectric Medicine Market: Transcranial Magnetic Stimulation (TMS), 2019-2030, $ mn
Figure 27. Asia Pacific Bioelectric Medicine Market: Pulsed Electromagnetic Field Therapy, 2019-2030, $ mn
Figure 28. Asia Pacific Bioelectric Medicine Market: Other Non-invasive Bioelectric Medicines, 2019-2030, $ mn
Figure 29. Breakdown of Asia Pacific Bioelectric Medicine Market by End User, 2020-2030, % of Sales Revenue
Figure 30. Asia Pacific Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%)
Figure 31. Asia Pacific Bioelectric Medicine Market: Hospitals and Clinics, 2019-2030, $ mn
Figure 32. Asia Pacific Bioelectric Medicine Market: Research Institutes, 2019-2030, $ mn
Figure 33. Asia Pacific Bioelectric Medicine Market: Individual Users, 2019-2030, $ mn
Figure 34. Breakdown of APAC Bioelectric Medicine Market by Country, 2019 and 2030, % of Revenue
Figure 35. Contribution to APAC 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 36. Bioelectric Medicine Market in Japan, 2019-2030, $ mn
Figure 37. Bioelectric Medicine Market in China, 2019-2030, $ mn
Figure 38. Bioelectric Medicine Market in Australia, 2019-2030, $ mn
Figure 39. Bioelectric Medicine Market in India, 2019-2030, $ mn
Figure 40. Bioelectric Medicine Market in South Korea, 2019-2030, $ mn
Figure 41. Bioelectric Medicine Market in Rest of APAC, 2019-2030, $ mn
Figure 42. Growth Stage of Asia Pacific Bioelectric Medicine Industry over the Forecast Period